SEC Filing Summary: Midatech Pharma PLC (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Midatech Pharma PLC, a foreign private issuer, for the month of February 2016. The filing date is February 29, 2016. The registrant is headquartered in Abingdon, Oxfordshire, United Kingdom. Note: The request metadata referenced "Biodexa Pharmaceuticals Plc," but the filing text explicitly identifies the registrant as "Midatech Pharma PLC."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a cover sheet to incorporate a press release by reference and contains no financial statements or quantitative data.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The document does not contain comparative financial data.
Guidance, Outlook, and Management Commentary
The filing incorporates by reference a press release dated February 23, 2016 (Exhibit 99.1), entitled "Midatech Pharma Recognises International Rare Disease Day 2016." The filing text itself does not provide specific details on guidance, outlook, risks, contingencies, or unusual items beyond the title of the attached press release.
Key Facts for Investor Verification
- Verify the correct registrant name is Midatech Pharma PLC, not Biodexa Pharmaceuticals Plc.
- Review the attached press release (Exhibit 99.1) for details regarding International Rare Disease Day 2016, as the filing text contains no substantive content.
- Confirm that no financial results or material financial updates were included in this specific Form 6-K submission.